Search Results
CAR T-cell therapy: how can we improve toxicity management
Managing CAR T-Cell Therapy Toxicity
Have we improved the management of CAR T toxicities?
Managing CAR T-cell therapy toxicities within treatment centres
Managing Acute Toxicities of CAR T-cell Therapy
Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T
Managing and treating CRS, neurological toxicity and cytopenias associated with CAR-T therapy
Mechanisms and management of short- and long-term CAR-T toxicities
FAQs From the American Society of Hematology Annual Meeting
What strategies are being explored to improve CAR-T cell therapy? #myeloma
Examining the Toxicities of CAR T-cell Therapy
Optimizing CAR-T therapy
